QHM-2025-7310 Local Enhanced Services

The NHS North East and North Cumbria Integrated Care Board is overseeing the procurement process for "QHM-2025-7310 Local Enhanced Services," focused on health services. This process falls under the Health Care Services (Provider Selection Regime) regulations of 2023 and involves a direct award process without prior publication of a call for competition. The contract, awarded to The Sele Medical Group, is intended for health services, including Population Health Management and Immune Modifying Drugs, with a delivery region in the North of England (UKC).

The procurement stage is complete, and the contract was signed on 1st October 2025, with an active status and a nominal value due to its activity-based nature. Services under this contract will span from 1st April 2025 to 31st March 2026, although they are noted to have been operational on an implied contract basis. This procurement opens avenues for businesses skilled in health services, particularly those in the North of England (UKC region), to explore partnership opportunities with the NHS, an influential public body.

The procurement is specifically suited for large-scale or specialised health service providers like The Sele Medical Group that can deliver complex services such as primary care phlebotomy and immune modifying treatments. Businesses looking to diversify into strategic healthcare partnerships could potentially grow by engaging with similar NHS procurement processes, even if the current contract follows a narrow award procedure.